Gad Thomas
Insider CIK 1753224 · YMAB See remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 75,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 242,200 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 132,500 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 64,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 16,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 16,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 143,169 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 16,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 100,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 107,500 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 130,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 91,450 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 110,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 60,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | U Tender | 2025-09-16 | 2025-09-18 | 67,681 | $8.60 | $582.1K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | U Tender | 2025-09-16 | 2025-09-18 | 245,486 | $8.60 | $2.11M | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer | 2025-09-16 | 2025-09-18 | 60,235 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | U Tender | 2025-09-16 | 2025-09-18 | 60,000 | $8.60 | $516.0K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2025-06-03 | 2025-06-05 | 103,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2025-06-03 | 2025-06-05 | 103,000 | $2.00 | $206.0K | 305,721 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2025-03-07 | 2025-03-11 | 10,810 | $5.23 | $56.5K | 202,721 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2025-01-17 | 2025-01-22 | 64,000 | — | $0 | 64,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2025-01-17 | 2025-01-22 | 32,000 | — | $0 | 213,531 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2024-09-19 | 2024-09-20 | 22,831 | — | $0 | 143,169 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2024-09-19 | 2024-09-20 | 22,831 | $4.38 | $100.0K | 181,531 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2024-09-16 | 2024-09-17 | 30,000 | $12.97 | $389.1K | 67,681 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2024-09-13 | 2024-09-17 | 65,000 | $13.47 | $875.5K | 97,681 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2024-06-11 | 2024-06-11 | 35,000 | $12.00 | $420.0K | 162,681 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2024-06-10 | 2024-06-11 | 35,000 | $12.03 | $421.1K | 197,681 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2024-05-23 | 2024-05-23 | 7,351 | $13.00 | $95.6K | 232,681 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2024-05-21 | 2024-05-23 | 25,000 | $12.00 | $300.0K | 240,032 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2024-03-05 | 2024-03-07 | 3,900 | $16.44 | $64.1K | 158,700 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2024-01-18 | 2024-01-22 | 132,500 | — | $0 | 132,500 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2024-01-18 | 2024-01-22 | 22,100 | — | $0 | 162,600 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2023-12-21 | 2023-12-26 | 50,000 | — | $0 | 103,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2023-12-21 | 2023-12-26 | 50,000 | $2.00 | $100.0K | 140,500 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2023-12-15 | 2023-12-15 | 50,000 | $6.61 | $330.5K | 265,032 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2023-12-14 | 2023-12-15 | 50,000 | $6.83 | $341.5K | 315,032 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2023-12-13 | 2023-12-15 | 50,000 | $6.58 | $329.0K | 365,032 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2023-11-21 | 2023-11-22 | 75,000 | $5.31 | $398.2K | 415,032 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2023-11-20 | 2023-11-22 | 75,000 | $5.30 | $397.5K | 490,032 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2023-11-06 | 2023-11-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2023-01-17 | 2023-01-19 | 243,200 | — | $0 | 243,200 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2023-01-17 | 2023-01-19 | 40,500 | — | $0 | 90,500 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2022-05-18 | 2022-05-19 | 60,000 | — | $0 | 60,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-02-09 | 2022-02-09 | 64,276 | $6.96 | $447.4K | 565,032 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-02-08 | 2022-02-09 | 125,863 | $7.01 | $882.3K | 629,308 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-02-07 | 2022-02-09 | 91,031 | $7.59 | $690.9K | 755,171 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-02-04 | 2022-02-07 | 101,104 | $7.70 | $778.5K | 846,202 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-02-03 | 2022-02-07 | 35,060 | $7.90 | $277.0K | 947,306 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2022-02-01 | 2022-02-03 | 8,000 | — | $0 | 153,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-02-01 | 2022-02-03 | 8,000 | $10.15 | $81.2K | 50,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2022-02-01 | 2022-02-03 | 8,000 | $2.00 | $16.0K | 58,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-01-24 | 2022-01-26 | 32,272 | $10.07 | $325.0K | 1,038,149 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-01-24 | 2022-01-26 | 55,783 | $10.96 | $611.4K | 982,366 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-01-21 | 2022-01-24 | 50,134 | $10.51 | $526.9K | 1,090,605 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-01-21 | 2022-01-24 | 20,184 | $11.35 | $229.1K | 1,070,421 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-01-20 | 2022-01-24 | 112,767 | $11.33 | $1.28M | 1,140,739 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-01-19 | 2022-01-20 | 69,414 | $10.89 | $755.9K | 1,253,506 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2022-01-18 | 2022-01-20 | 8,000 | — | $0 | 161,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-01-18 | 2022-01-20 | 8,000 | $11.54 | $92.3K | 50,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-01-18 | 2022-01-20 | 400 | $11.46 | $4.6K | 1,322,920 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2022-01-18 | 2022-01-20 | 8,000 | $2.00 | $16.0K | 58,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2021-12-14 | 2021-12-16 | 110,000 | — | $0 | 110,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | G Gift | 2021-12-14 | 2021-12-16 | 60,000 | — | $0 | 1,383,320 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | G Gift | 2021-12-14 | 2021-12-16 | 60,000 | — | $0 | 1,323,320 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-12-07 | 2021-12-08 | 10,000 | $17.58 | $175.8K | 1,383,320 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-08 | 4,000 | $16.50 | $66.0K | 1,393,320 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-08 | 40,000 | $16.48 | $659.2K | 1,397,320 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-11-30 | 2021-12-01 | 4,000 | $16.98 | $67.9K | 1,437,320 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-11-30 | 2021-12-01 | 7,770 | $17.04 | $132.4K | 1,441,320 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-11-30 | 2021-12-01 | 12,800 | $17.11 | $219.0K | 1,449,090 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-11-30 | 2021-12-01 | 600 | $16.94 | $10.2K | 1,461,890 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-11-29 | 2021-12-01 | 22,437 | $17.16 | $385.0K | 1,462,490 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2021-11-23 | 2021-11-26 | 50,000 | — | $0 | 169,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2021-11-23 | 2021-11-26 | 50,000 | $2.00 | $100.0K | 100,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-11-23 | 2021-11-26 | 50,000 | $17.06 | $853.0K | 50,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-11-16 | 2021-11-18 | 4,000 | $19.33 | $77.3K | 1,484,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-10-29 | 2021-11-01 | 4,000 | $24.82 | $99.3K | 1,488,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-10-15 | 2021-10-19 | 4,000 | $27.20 | $108.8K | 1,492,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-09-30 | 2021-10-04 | 4,000 | $28.26 | $113.0K | 1,496,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-09-15 | 2021-09-17 | 4,000 | $33.64 | $134.6K | 1,500,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2021-09-07 | 2021-09-07 | 50,000 | — | $0 | 219,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2021-09-07 | 2021-09-07 | 50,000 | $2.00 | $100.0K | 50,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-09-02 | 2021-09-07 | 50,000 | $33.18 | $1.66M | 1,504,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-08-17 | 2021-08-17 | 1,779 | $28.96 | $51.5K | 1,554,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-08-16 | 2021-08-17 | 22,111 | $29.33 | $648.5K | 1,556,706 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-08-16 | 2021-08-17 | 4,000 | $29.14 | $116.6K | 1,578,817 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-08-13 | 2021-08-17 | 1,110 | $31.01 | $34.4K | 1,582,817 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-08-03 | 2021-08-05 | 4,000 | $33.73 | $134.9K | 1,583,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-07-20 | 2021-07-21 | 4,000 | $32.47 | $129.9K | 1,587,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-07-07 | 2021-07-08 | 4,000 | $31.87 | $127.5K | 1,591,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-06-30 | 2021-07-02 | 4,000 | $33.86 | $135.4K | 1,595,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-06-14 | 2021-06-15 | 4,000 | $35.80 | $143.2K | 1,599,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-05-28 | 2021-06-01 | 4,000 | $36.95 | $147.8K | 1,603,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-05-18 | 2021-05-20 | 4,000 | $34.07 | $136.3K | 1,607,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2021-04-26 | 2021-04-28 | 7,000 | — | $0 | 269,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-04-26 | 2021-04-28 | 7,000 | $27.96 | $195.7K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2021-04-26 | 2021-04-28 | 7,000 | $2.00 | $14.0K | 7,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2021-04-12 | 2021-04-14 | 7,000 | — | $0 | 276,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-14 | 4,000 | $26.60 | $106.4K | 1,611,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-14 | 7,000 | $26.61 | $186.3K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2021-04-12 | 2021-04-14 | 7,000 | $2.00 | $14.0K | 7,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2021-04-01 | 2021-04-05 | 9,000 | — | $0 | 283,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-04-01 | 2021-04-05 | 9,000 | $30.26 | $272.3K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-04-01 | 2021-04-05 | 6,000 | $30.27 | $181.6K | 1,615,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2021-04-01 | 2021-04-05 | 9,000 | $2.00 | $18.0K | 9,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2021-03-15 | 2021-03-17 | 7,000 | — | $0 | 292,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-03-15 | 2021-03-17 | 4,000 | $36.78 | $147.1K | 1,621,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2021-03-15 | 2021-03-17 | 7,000 | $2.00 | $14.0K | 7,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-03-15 | 2021-03-17 | 7,000 | $36.79 | $257.5K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | J Other | 2021-03-10 | 2021-03-12 | 1,029,927 | — | $0 | 1,625,927 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2021-03-01 | 2021-03-03 | 9,000 | — | $0 | 299,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2021-03-01 | 2021-03-03 | 9,000 | $2.00 | $18.0K | 9,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-03 | 9,000 | $35.51 | $319.6K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-03 | 6,000 | $35.50 | $213.0K | 596,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2021-02-16 | 2021-02-18 | 7,000 | — | $0 | 308,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-02-16 | 2021-02-18 | 4,000 | $47.09 | $188.4K | 602,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-02-16 | 2021-02-18 | 7,000 | $47.08 | $329.6K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2021-02-16 | 2021-02-18 | 7,000 | $2.00 | $14.0K | 7,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2021-02-01 | 2021-02-03 | 7,000 | — | $0 | 315,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-02-01 | 2021-02-03 | 7,000 | $41.99 | $293.9K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2021-02-01 | 2021-02-03 | 7,000 | $2.00 | $14.0K | 7,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-02-01 | 2021-02-03 | 4,000 | $41.97 | $167.9K | 606,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2021-01-19 | 2021-01-21 | 7,000 | — | $0 | 322,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-01-19 | 2021-01-21 | 4,000 | $46.56 | $186.2K | 610,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2021-01-19 | 2021-01-21 | 7,000 | $2.00 | $14.0K | 7,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-01-19 | 2021-01-21 | 7,000 | $46.51 | $325.6K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2021-01-05 | 2021-01-07 | 7,000 | — | $0 | 329,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2021-01-05 | 2021-01-07 | 7,000 | $2.00 | $14.0K | 7,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-01-05 | 2021-01-07 | 7,000 | $49.36 | $345.5K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-01-05 | 2021-01-07 | 4,000 | $49.31 | $197.2K | 614,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2020-12-28 | 2020-12-30 | 7,000 | — | $0 | 336,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-12-28 | 2020-12-30 | 7,000 | $51.98 | $363.9K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2020-12-28 | 2020-12-30 | 7,000 | $2.00 | $14.0K | 7,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2020-12-16 | 2020-12-17 | 7,000 | — | $0 | 343,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-12-16 | 2020-12-17 | 7,000 | $53.01 | $371.1K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2020-12-16 | 2020-12-17 | 7,000 | $2.00 | $14.0K | 7,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2020-12-15 | 2020-12-16 | 91,450 | — | $0 | 91,450 | SEC↗ |
| VYMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 4,000 | $52.89 | $211.6K | 618,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2020-12-11 | 2020-12-14 | 50,000 | $2.00 | $100.0K | 50,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-12-11 | 2020-12-14 | 50,000 | $51.17 | $2.56M | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2020-12-10 | 2020-12-14 | 50,000 | — | $0 | 400,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2020-12-10 | 2020-12-14 | 50,000 | — | $0 | 350,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-12-10 | 2020-12-14 | 50,000 | $50.75 | $2.54M | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2020-12-10 | 2020-12-14 | 50,000 | $2.00 | $100.0K | 50,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-12-01 | 2020-12-02 | 4,000 | $51.42 | $205.7K | 622,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-11-16 | 2020-11-17 | 4,000 | $46.17 | $184.7K | 626,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-11-02 | 2020-11-05 | 4,000 | $43.69 | $174.8K | 630,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-10-15 | 2020-10-19 | 4,000 | $39.15 | $156.6K | 634,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-10-01 | 2020-10-02 | 4,000 | $38.88 | $155.5K | 638,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-09-15 | 2020-09-17 | 4,000 | $40.81 | $163.2K | 642,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2020-09-14 | 2020-09-15 | 22,569 | — | $0 | 450,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-09-14 | 2020-09-15 | 22,569 | $41.00 | $925.3K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2020-09-14 | 2020-09-15 | 22,569 | $2.00 | $45.1K | 22,569 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2020-09-11 | 2020-09-15 | 13,571 | — | $0 | 472,569 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2020-09-11 | 2020-09-15 | 13,571 | $2.00 | $27.1K | 13,571 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-09-11 | 2020-09-15 | 13,571 | $40.33 | $547.3K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2020-09-10 | 2020-09-15 | 13,860 | — | $0 | 486,140 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2020-09-10 | 2020-09-15 | 13,860 | $2.00 | $27.7K | 13,860 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-09-10 | 2020-09-15 | 13,860 | $41.58 | $576.3K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-09-01 | 2020-09-02 | 4,000 | $41.60 | $166.4K | 646,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-08-17 | 2020-08-19 | 4,000 | $40.35 | $161.4K | 650,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-08-12 | 2020-08-13 | 13,000 | $39.51 | $513.6K | 654,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-08-11 | 2020-08-13 | 37,000 | $40.06 | $1.48M | 667,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-08-03 | 2020-08-05 | 4,000 | $36.51 | $146.0K | 704,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-07-15 | 2020-07-17 | 4,000 | $40.06 | $160.2K | 708,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-07-01 | 2020-07-06 | 4,000 | $42.04 | $168.2K | 712,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-06-15 | 2020-06-16 | 4,000 | $43.45 | $173.8K | 716,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-06-04 | 2020-06-05 | 4,000 | $41.61 | $166.4K | 720,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-05-27 | 2020-05-29 | 50,000 | $39.01 | $1.95M | 724,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-05-18 | 2020-05-20 | 4,000 | $39.65 | $158.6K | 774,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-05-12 | 2020-05-14 | 50,000 | $39.04 | $1.95M | 778,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-05-01 | 2020-05-05 | 4,000 | $32.35 | $129.4K | 828,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-04-13 | 2020-04-15 | 4,000 | $29.43 | $117.7K | 832,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-03-16 | 2020-03-18 | 4,000 | $18.01 | $72.0K | 836,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-03-02 | 2020-03-04 | 4,000 | $29.18 | $116.7K | 840,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-02-18 | 2020-02-20 | 4,000 | $32.78 | $131.1K | 844,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-02-10 | 2020-02-11 | 4,000 | $33.03 | $132.1K | 848,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-01-27 | 2020-01-29 | 4,000 | $35.06 | $140.2K | 852,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-01-13 | 2020-01-15 | 4,000 | $30.90 | $123.6K | 856,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2020-01-07 | 2020-01-09 | 130,000 | — | $0 | 130,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | J Other | 2019-12-30 | 2019-12-31 | 201 | — | $0 | 1,030,356 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-12-16 | 2019-12-17 | 4,000 | $31.54 | $126.2K | 860,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | G Gift | 2019-12-13 | 2019-12-17 | 8,000 | — | $0 | 864,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-12-02 | 2019-12-04 | 4,000 | $32.48 | $129.9K | 872,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-11-18 | 2019-11-19 | 4,000 | $28.41 | $113.6K | 876,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-11-04 | 2019-11-05 | 4,000 | $30.10 | $120.4K | 880,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-10-21 | 2019-10-22 | 4,000 | $27.59 | $110.4K | 884,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-10-07 | 2019-10-08 | 4,000 | $25.21 | $100.8K | 888,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-09-16 | 2019-09-17 | 4,000 | $30.59 | $122.4K | 892,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-09-03 | 2019-09-05 | 4,000 | $25.77 | $103.1K | 896,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-08-19 | 2019-08-20 | 4,000 | $27.70 | $110.8K | 900,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-08-05 | 2019-08-06 | 4,000 | $21.78 | $87.1K | 904,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-07-22 | 2019-07-23 | 4,000 | $22.54 | $90.2K | 908,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-07-08 | 2019-07-10 | 4,000 | $22.40 | $89.6K | 912,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-06-24 | 2019-06-25 | 4,000 | $21.77 | $87.1K | 916,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-06-10 | 2019-06-11 | 4,000 | $22.79 | $91.2K | 920,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-06-03 | 2019-06-04 | 4,000 | $20.03 | $80.1K | 924,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-05-28 | 2019-05-29 | 6,000 | $20.21 | $121.3K | 928,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-05-13 | 2019-05-14 | 6,000 | $20.61 | $123.7K | 934,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-04-11 | 2019-04-11 | 150,000 | $25.80 | $3.87M | 940,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-04-09 | 2019-04-11 | 99,200 | $26.02 | $2.58M | 1,090,800 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-04-09 | 2019-04-11 | 800 | $26.93 | $21.5K | 1,090,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2018-12-11 | 2018-12-13 | 107,500 | — | $0 | 107,500 | SEC↗ |